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Glycine receptors (GlyRs) mediate inhibitory neurotransmission and are targets for
alcohols and anesthetics in brain. GlyR transmembrane (TM) domains contain critical
residues for alcohol/anesthetic action: amino acid A288 in TM3 forms crosslinks with
TM1 (I229) in the adjacent subunit as well as TM2 (S267) and TM4 (Y406, W407, I409,
Y410) in the same subunit. We hypothesized that these residues may participate in
intra-subunit and inter-subunit sites of alcohol/anesthetic action. The following double
and triple mutants of GLRA1 cDNA (encoding human glycine receptor alpha 1 subunit)
were injected into Xenopus laevis oocytes: I229C/A288C, I229C/A288C/C290S,
A288C/Y406C, A288C/W407C, A288C/I409C, and A288C/Y410C along with the
corresponding single mutants and wild-type GLRA1. Butanol (22 mM) or isoflurane (0.6
mM) potentiation of GlyR-mediated currents before and after application of the cysteine
crosslinking agent HgCl2 (10 µM) was measured using two-electrode voltage clamp
electrophysiology. Crosslinking nearly abolished butanol and isoflurane potentiation
in the I229C/A288C and I229C/A288C/C290S mutants but had no effect in single
mutants or wild-type. Crosslinking also inhibited butanol and isoflurane potentiation in
the TM3-4 mutants (A288C/Y406C, A288C/W407C, A288C/I409C, A288C/Y410C) with
no effect in single mutants or wild-type. We extracted proteins from oocytes expressing
I229C/288C, A288C/Y410C, or wild-type GlyRs, used mass spectrometry to verify their
expression and possible inter-subunit dimerization, plus immunoblotting to investigate
the biochemical features of proposed crosslinks. Wild-type GlyR subunits measured
about 50 kDa; after crosslinking, the dimeric/monomeric 100:50 kDa band ratio was
significantly increased in I229C/288C but not A288C/Y410C mutants or wild-type,
providing support for TM1-3 inter-subunit and TM3-4 intra-subunit crosslinking. A GlyR
homology model based on the GluCl template provides further evidence for a multi-site
model for alcohol/anesthetic interaction with human GLRA1.
Keywords: GLRA1, alcohol, anesthetic, Xenopus oocytes, GluCl model, mass spectrometry, immunoblotting,
proteomics
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INTRODUCTION
Glycine receptors (GlyRs) are members of the Cys-loop family
of pentameric ligand-gated ion channels, which also include the
nicotinic acetylcholine receptor (nAChR), serotonin-3 receptor
(5-HT3R), and γ-aminobutyric acid type A receptor (GABAAR).
GlyRs mediate the majority of inhibitory neurotransmission in
the brain stem and spinal cord (Legendre, 2001) and are also
expressed in the amygdala, cortex, cerebellum, hippocampus,
striatum, nucleus accumbens, and the ventral tegmental area (van
den Pol and Gorcs, 1988; Takahashi et al., 1992; Fatima-Shad
and Barry, 1993; Molander and Soderpalm, 2005; Baer et al.,
2009; Jonsson et al., 2012). Functional GlyRs are composed of
five subunits positioned around a central chloride ion channel.
Each subunit consists of an extracellular N-terminal domain, a
transmembrane (TM) domain with four alpha helical segments
(TM1, TM2, TM3, and TM4), an intracellular loop between
TM3 and TM4, and an extracellular C-terminal segment. Four
GlyR α subunits (1-4) and one β subunit have been identified
(Grenningloh et al., 1990; Harvey et al., 2000, 2004), which
can assemble to form either homomeric α or heteromeric αβ
receptors (Lynch, 2004).
Alcohols and volatile anesthetics potentiate GlyR function
(Harrison et al., 1993; Mascia et al., 1996) and likely share
common sites of action (Mihic et al., 1997; Beckstead et al., 2001).
Critical amino acid residues for alcohol/anesthetic enhancement
of the human alpha 1 subunit have been identified in TM1 (I229),
TM2 (S267), and TM3 (A288) (Mihic et al., 1997; Mascia et al.,
2000; Lobo et al., 2004a). Less is known about TM4 residues
(Bertaccini et al., 2010), but together with TM1-3 residues, they
may also participate in water-filled, alcohol/anesthetic sites of
action within the TM domain (Mascia et al., 2000; Jenkins et al.,
2001; Trudell and Harris, 2004; Lobo et al., 2004a, 2006). For
example, A288 in TM3 forms crosslinks with the critical residues
for alcohol/anesthetic action in TM1 (I229) (Lobo et al., 2008),
TM2 (S267) (Lobo et al., 2004b), and TM4 (Y406, W407, I409,
and Y410) (McCracken et al., 2010). In addition, sites for alcohol
have been identified near the ion pore in nAChRs (Borghese et al.,
2003) and GABAARs (Borghese et al., 2016).
Crosslinking of A288 in TM3 with Y406, W407, I409, or
Y410 in TM4 supports the assignment of these TM4 residues
as intra-subunit facing (Bertaccini et al., 2010; McCracken
et al., 2010). X-ray structures of anesthetics bound to the
bacterial homolog GLIC (Gloeobacter violaceus ligand-gated
ion channel) and photolabeling of GABAARs further support
action at an intra-subunit cavity (Nury et al., 2010; Yip et al.,
2013). However, other research proposed an inter-subunit drug
pocket (Bali et al., 2009), suggesting that the homologous
residue to A288 in TM3 of the GABAAR is oriented toward
the subunit interface, such that it is able to form crosslinks
with TM1 residues of an adjacent subunit. Photoaffinity labeling
indicated that multiple classes of general anesthetics act at an
inter-subunit site (Stewart et al., 2008; Zhong et al., 2008; Li
et al., 2010; Chiara et al., 2013). Crystallography, paired with
functional studies in GLIC, was used to compare the receptors
in the presence and absence of ethanol and bromoethanol and
provided support for inter-subunit binding cavities (Sauguet
et al., 2013). A multi-site hypothesis has also emerged suggesting
that alcohols and anesthetics act at both intra- and inter-subunit
GlyR sites. This hypothesis resulted largely from mutagenesis
studies of the bacterial GLIC and invertebrate GluCl (glutamate-
gated chloride channel) homologs, molecular simulations, and
homology modeling (Howard et al., 2011; Murail et al., 2012;
Yoluk et al., 2013). Crosslinking studies of the mammalian
GABAAR provided further evidence for this model (Borghese
et al., 2014). Recent electron cryo-microscopy structures of
the zebrafish GlyR in the glycine-, glycine/ivermectin-, and
strychnine-bound states (Du et al., 2015) have also provided
strong support for our homology models.
In the present study, we used cysteine mutagenesis in relevant
TM locations and tested the proximity of cysteine pairs using
crosslinking agents, electrophysiology, immunoblotting, mass
spectrometry (MS), and computer modeling. We determined
if crosslinking of A288 in TM3 with critical residues in
TM1 or TM4 alters alcohol or volatile anesthetic potentiation
of the human GLRA1 subunit and if drug binding sites
likely exist within a subunit or between adjacent subunits.
Evidence for intra-subunit vs. inter-subunit sites of drug action
was inferred using electrophysiology, biochemistry, proteomics,
and structural modeling, although these approaches do not
specifically distinguish between active vs. allosteric sites.
MATERIALS AND METHODS
Materials
Adult female Xenopus laevis frogs were purchased from Nasco
(Fort Atkinson, WI). Glycine was purchased from Bio-Rad
Laboratories (Hercules, CA), isoflurane was from Marsam
Pharmaceuticals, Inc. (Cherry Hill, NJ), and all other chemicals
and buffer ingredients were from Sigma-Aldrich (St. Louis, MO).
Site-Directed Mutagenesis
Point mutations in GLRA1 cDNA (subcloned in the pBKCMV
N/B-200 vector) were made using a QuickChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA). Single
mutants (A288C, I229C, Y406C, W407C, I409C, Y410C),
double mutants (I229C/A288C, I229C/C290S, A288C/Y406C,
A288C/W407C, A288C/I409C, A288C/Y410C), and a triple
mutant (I229C/A288C/C290S) were constructed. All point
mutations were verified by DNA sequencing in the core facility
at The University of Texas at Austin.
Oocyte Isolation and cDNA Injection
Adult Xenopus females were housed in a state-of-the-art frog
facility designed and installed by Aquatic Habitats located in
the Animal Resources Center at The University of Texas at
Austin. Frogs were anesthetized in a tricaine immersion bath and
portions of ovary were surgically extracted in accordance with an
approved Institutional Animal Care andUse Committee protocol
(AUP-2015-00205). Mature oocytes were manually isolated,
treated in 0.5 mg/ml collagenase (type IA), and subsequently
injected with 30 nl of nuclease-free water containing GLRA1
(1.5 ng/30 nl) wild-type or mutant cDNA into the nucleus.
Injected oocytes were incubated at 15◦C in sterile modified
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Barth’s solution (MBS containing: 88 mM NaCl, 1 mM KCl,
2.4 mM NaHCO3, 19 mM HEPES, 0.82 mM MgSO4, 0.33 mM
Ca(NO3)2, 0.91 mM CaCl2, 10,000 units/L penicillin, 50 mg/L
gentamicin, 90 mg/L theophylline, 220 mg/L sodium pyruvate,
pH 7.5) for 1-7 days.
Electrophysiological Recording
Oocytes were placed in a 100-µl bath with the animal poles facing
upwards and impaled with two high-resistance (0.5–10M) glass
electrodes filled with 3M KCl. There were two ground wires (on
either side of the oocyte) in the bath and both were plugged
into the amplifier. In addition, two electrodes (one monitors
voltage, the other injects current in voltage clamp mode) were
inserted into the oocyte. Cells were voltage clamped at −70 mV
using an OC-725C oocyte clamp (Warner Instruments, Hamden,
CT) and perfused with MBS at a rate of 2 ml/min using a
Masterflex USA peristaltic pump (Cole Parmer Instrument Co.,
VernonHills, IL) through 18-gauge polyethylene tubing. All drug
solutions were freshly prepared in MBS. Currents were acquired
using a Powerlab 4/30 digitizer with LabChart version 7 software
(ADInstruments, Bella Vista, NSW, Australia). Peak currents
were measured and used in data analysis. Currents observed in
the presence of glycine plus modulators were compared with
currents generated by glycine alone.
Alcohol and Volatile Anesthetic Responses before
and after Crosslinking
The glycine EC5−10 (the concentration that produced 5–10%
of the maximal response) was determined for each oocyte after
a 15-s application of the maximal glycine concentration (100
mM), and this served as the test concentration. Individual
oocytes and receptors vary in glycine sensitivity, and thus we
indicate glycine EC5−10 rather than specifying the different
glycine concentrations that were used in each set of experiments.
We studied glycine EC5−10 because potentiation by alcohols
and anesthetics is best observed at these concentrations. Typical
EC50 values for wild-type and mutant receptors are listed in
McCracken et al. (2010). The test concentration was applied
for 30 s followed by a 5-min washout. Two consecutive glycine
applications were applied to ensure that responses were stable.
Butanol or isoflurane was pre-applied for 1 min and then co-
applied with glycine for 30 s followed by a 10-min washout.
The test glycine concentration was reapplied, and the percent
potentiation of the glycine-induced current by butanol or
isoflurane was calculated for each oocyte. HgCl2 (10 µM)
was applied for 1 minute (in the absence of glycine for the
A288C/W407C and A288C/Y410C mutants and in the presence
of 100 mM glycine for the A288C/Y406C, A288C/I409C,
I229C/A288C, and I229C/A288C/C290S mutants) followed by a
15-min washout (McCracken et al., 2010). The maximal glycine
concentration was then reapplied and the test concentration
(EC5−10) recalculated. The potentiation of glycine-induced
current by the alcohol or anesthetic was measured again as
described above. The concentrations of butanol (22 mM) or
isoflurane (0.6 mM) used correspond to approximately two
times the minimal alveolar concentration needed to suppress
movement to a painful stimulus.
Oxidation with H2O2 and Reduction with DTT
In addition to the chemical crosslinking agent HgCl2 that
was used to form S-Hg-S bonds, we replicated those results
using oxidation of the thiol groups of the double mutants to
form S-S bonds. The maximal glycine concentration (100 mM)
was applied for 15–20 s followed by a 15-min washout. This
concentration was reapplied and the second response served at
the test response. H2O2 (0.5%) was then applied in the presence
of 100 mM glycine for 1 min followed by a 15-min washout.
The oocytes were unclamped during application and washout
of H2O2, but remained impaled by the electrodes as previously
described (Lobo et al., 2008; McCracken et al., 2010). After re-
clamping to −70 mV, 100 mM glycine was applied and the
responses were compared to the glycine test response before
H2O2 application. Glycine (100 mM) was applied a second
time and served as the new test response. Then crosslinks were
reduced by applying dithiothreitol (DTT, 10 mM) for 3 min to
unclamped oocytes followed by a 15-min washout period before
being re-clamped. Glycine (100 mM) was reapplied and the
responses were compared to the glycine test response following
H2O2 application.
Data analysis
Three to six oocytes were used per experimental condition (see
figure legends). For each receptor tested with HgCl2, repeated
measures t-tests were used to detect differences before and after
crosslinking (i.e., pre- vs. post-HgCl2 or pre- vs. post- H2O2).
For the crosslinking experiments using the oxidizing agent H2O2
and reducing agent DTT, a one-way ANOVA with Tukey’s post-
hoc test was used to examine significant differences between
conditions (pre-H2O2 vs. post-H2O2 vs. post-DTT). GraphPad
Prism software (La Jolla, CA) was used for all analyses, and the
threshold for statistical significance was set at P < 0.05.
Protein Extraction
Oocytes weremanually isolated and injected with 1.5 ng/nl cDNA
as described above and then incubated in MBS for 5–7 days
at 13◦C. Groups of 25 oocytes were pooled for each condition.
Oocytes in the crosslinked group were treated with 0.5% H2O2
by bath perfusion according to the protocol described earlier for
HgCl2 application (also see McCracken et al., 2010). Following a
15-minute washout, oocytes were homogenized in 1 ml of Wash
Buffer (0.1MEDTA, pH 7.5; 0.1MEGTA, pH 7.5; 2MNaCl; 0.1M
NaH2PO4, pH 7.5) with protease inhibitors (5 mM benzamidine
and 15 mM iodoacetamide), and then centrifuged at 4◦C for
30 min at 13,500 rpm. The supernatant was removed, and 250
µl of Extraction Buffer (Wash Buffer + 2% Triton + 5 mM
benzamidine+ 15mM iodoacetamide) was added. The pellet was
resuspended, rotated at 4◦C for 2 h, and then centrifuged at 4◦C
for 30min at 13,500 rpm. The supernatant containing the protein
extract was collected and an aliquot was subjected to Bio-Rad
protein assay. A similar protein extraction protocol in Xenopus
oocytes was described previously (Bali et al., 2009).
Immunoblotting
Equal amounts of soluble proteins (unless noted otherwise)
extracted from oocytes were resolved by SDS-PAGE
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under non-reducing conditions and electrotransferred to a
polyvinylidene fluoride membrane in a buffer containing 25
mM Tris, 192 mM glycine, 0.1% (w/v) SDS, and 20% (v/v)
methanol for 1 h at 18 V. Membranes were briefly rinsed in a
buffer containing 10 mM Tris HCl (pH 8.0), 150 mM NaCl,
and 0.01% (v/v) Tween-20 (TBS-T) and then incubated at room
temperature for 1 h in TBS-T containing 5% (w/v) skimmedmilk
powder to block non-specific binding of antibodies. Incubation
of membranes with rabbit polyclonal antibody to GlyR alpha
1 (catalog number ab475, Abcam, Cambridge, England) was
performed in TBS-T containing 1% skimmed milk and 1%
BSA powders (w/v) for 2 h at room temperature, followed by
three 10-min washes with TBS-T alone. Membranes were then
incubated for 1 h at room temperature with an appropriate
secondary antibody conjugated to horseradish peroxidase
(HRP), diluted in TBS-T containing 1% skimmed milk and 1%
BSA powders, followed by three 5-min washes with TBS-T. After
the final wash, blots were immediately developed by applying the
Enhanced Chemi-Luminescence (ECL) reagent (Pierce Chemical
Co., Rockford, IL) for 2 min, and then a Kodak Image Station
2000 MM (Eastman Kodak, Rochester, NY) was used to acquire
images.
Protein Identification
For mass spectrometry experiments, 60 µg of protein obtained
from oocytes for each condition were resolved by 12% SDS-
PAGE under non-reducing conditions and the resulting gels
were subjected to Coomassie staining (Imperial Protein Stain,
Thermo Fisher Scientific, Waltham, MA). Discrete specific gel
bands of interest ranging from ∼30 to ∼140 kDa were excised,
washed 3 times with ultrapure water, and digested in-gel with
modified porcine trypsin protease (Promega, Fitchburg, WI).
The digested tryptic peptides were desalted using a Zip-tip C18
(Millipore, Billerica, MA). Peptides were eluted from the Zip-tip
with 0.5µl of Matrix Solution (α-cyano-4-hydroxycinnamic acid,
5mg/ml in 50% acetonitrile, 0.1% trifluoroacetic acid, and 25mM
ammonium bicarbonate) and spotted on a MALDI plate.
Mass Spectrometry
MALDI-ToF MS and ToF/ToF tandem MS/MS were performed
on an AB SCIEX ToF/ToFTM 5800 System (AB SCIEX,
Framingham, MA). MALDI-ToF mass spectra were acquired
in reflectron positive ion mode, averaging 4000 laser shots
per spectrum. ToF/ToF tandem MS fragmentation spectra
were acquired for each sample, averaging 4000 laser shots per
fragmentation spectrum on each of the 7–10 most abundant ions
present in each sample (excluding trypsin autolytic peptides and
other known background ions). Protein identification by MS was
performed by Applied Biomics (Hayward, CA).
Database Search
The resulting peptide mass and the associated fragmentation
spectra were submitted to GPS Explorer workstation equipped
with MASCOT search engine (Matrix Science, Boston, MA) to
search the Swiss-Prot database. Searches were performed without
constraining protein molecular weight or isoelectric point, with
variable carbamidomethylation of cysteine and oxidation of
methionine residues, and with one missed cleavage allowed in
the search parameters. Proteins with a protein score C.I. % or
total ion C.I. % greater than 90 are considered confidence hits.
When the protein score C.I. % was lower than 90, confidence
was assumed on the basis of different species background and
complementary immunoblot evidence.
Quantification of Band Ratios
ImageJ64 software (National Institutes of Health, Bethesda, MD)
was used to process and quantify GLRA1-labeled band intensity
at approximately 50 and 100 kDa, which correspond to the loci at
which monomeric and dimeric GlyR subunits, respectively, were
identified by MS. These band intensities were then calculated
and reported as direct ratios (100:50 kDa), and statistically
significant differences in band ratios between the uncrosslinked
and crosslinked conditions were measured for the representative
TM1-3 mutant, TM3-4 mutant, and wild-type using t-tests (P <
0.05).
Molecular Modeling
A homology model of homo-pentameric GlyR alpha 1 subunits
was built by threading the primary sequence onto the X-ray
structure of the eukaryotic GluCl (PDB ID 3RHW) (Hibbs and
Gouaux, 2011). The cytoplasmic TM3-4 loop was trimmed to
match the length of the GluCl template in that region (Bertaccini
and Trudell, 2002). The modeling and subsequent refinement
were essentially as described previously (Bertaccini et al., 2005)
using the Discovery Studio software suite (Biovia, SanDiego, CA)
(McCracken et al., 2010).
RESULTS
Effect of TM1-TM3 Inter-Subunit
Crosslinking on Alcohol and Anesthetic
Modulation
We determined if crosslinking of accessible residues A288 in
TM3 and I229 in TM1 alters alcohol or volatile anesthetic
enhancement of GlyR function in Xenopus oocytes. The
I229C/A288C double and I229C/A288C/C290S triple mutants
and corresponding single mutants were each expressed in
oocytes. We prepared the triple mutation in order to rule
out possible crosslinking with the native wild-type C290. The
mutants form functional homomeric channels, although the
GlyR sensitivity differs for some of the mutants (Lobo et al.,
2008). We measured the potentiation of submaximal (EC5−10)
glycine-induced current by 22 mM butanol before and after
application of the crosslinking agent HgCl2. As previously
reported (Lobo et al., 2008), agonist-induced rotation within
the TM domain appears to be necessary for the formation of
crosslinks in the I229C/A288C mutant; thus HgCl2 (10 µM) was
applied in the presence of a maximal concentration of glycine
(100 mM). HgCl2had no effect on butanol potentiation in the
wild-type or single mutants, but nearly abolished the potentiation
in the double and triple mutants (Figure 1A).
We then measured the potentiation of submaximal (EC5−10)
glycine-induced current by 0.6 mM isoflurane before and after
application of HgCl2. As described above for butanol, HgCl2 was
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FIGURE 1 | Effect of crosslinking on alcohol/anesthetic responses in
TM1-3 mutants. Potentiation of EC5−10 glycine responses by 22 mM
butanol (A) or 0.6 mM isoflurane (B) before and after application of the
crosslinking agent HgCl2. HgCl2 (10 µM) was applied to wild-type, single
mutants, and I229C/A288C and I229C/A288C/C290S mutants in the
presence of 100 mM glycine (i.e., the activated/desensitized state). Values
represent mean ± SEM from 4 to 5 oocytes. Repeated measures t-tests were
used to test differences between pre-and post-HgCl2 conditions (*P < 0.05
compared to the pre-HgCl2 condition for each receptor).
applied in the presence of 100 mM glycine. HgCl2 had no effect
on isoflurane potentiation in wild-type or single mutants, but
nearly eliminated the potentiation in the I229C/A288C double
and I229C/A288C/C290S triple mutants (Figure 1B).
Effect of TM3-4 Intra-Subunit Crosslinking
on Alcohol and Anesthetic Modulation
We determined if crosslinking of A288 in TM3 with critical TM4
residues alters alcohol or volatile anesthetic enhancement
of GlyR function in oocytes. The four double cysteine
mutants (A288C/Y406C, A288C/W407C, A288C/I409C,
and A288C/Y410C), previously shown to form crosslinks
(McCracken et al., 2010), and the corresponding single mutants
were each expressed in oocytes. The mutants formed functional
channels, although the mutations can produce altered glycine
sensitivity (Lobo et al., 2006; McCracken et al., 2010).
As previously described (McCracken et al., 2010), 10 µM
HgCl2 was applied to the A288C/W407C and A288C/Y410C
double mutants and corresponding single mutants in the
absence of glycine (i.e., in the closed/resting state; Figure 2A).
However, agonist-induced rearrangement of the TM domain is
necessary for the formation of crosslinks in A288C/Y406C and
A288C/I409C; therefore HgCl2 was applied in the presence of
FIGURE 2 | Effect of crosslinking on alcohol responses in TM3-4
mutants. Potentiation of EC5−10 glycine responses by 22 mM butanol before
and after HgCl2. (A) HgCl2 (10 µM) was applied to wild-type, single mutants,
and double mutants (A288C/W407C, A288C/Y410C) in the absence of
glycine (i.e., the resting/closed state). (B) HgCl2 (10 µM) was applied to
wild-type, single mutants, and double mutants (A288C/Y406C, A288C/I409C)
in the presence of 100 mM glycine (activated/desensitized state). Values
represent mean ± SEM from 4 to 5 oocytes. Data from wild-type and A288C
receptors were combined across experiments and are represented in (A,B)
and Figure 1A. Repeated measures t-tests were used to detect differences
between the pre-and post-HgCl2 conditions (*P < 0.05 compared to the
pre-HgCl2 condition for each receptor).
a maximal glycine concentration (i.e., in the open/desensitized
state) for these double and corresponding single mutants
(Figure 2B). HgCl2 had no effect on 22 mM butanol potentiation
of glycine responses in wild-type or single mutants, but
decreased butanol potentiation in all four double cysteine
mutants (Figures 2A,B). Figure 3 shows representative tracings
of the butanol effects before and after crosslinkingon glycine-
induced currents in individual oocytes expressing wild-type or
A288C/Y410C GlyRs.
Next we compared the potentiation of EC5−10 glycine currents
by 0.6 mM isoflurane before and after HgCl2 applied during the
closed or open channel conditions described previously for each
mutant. HgCl2 had no effect on wild-type or single mutants, but
potently inhibited isoflurane potentiation in the double cysteine
TM3-4 mutants (Figures 4A,B).
We addressed the possibility that the diminished
butanol/isoflurane effects in the TM3-4 mutants after HgCl2
might be due to Hg2+ binding to each of the substituted cysteines
and forming S-Hg-Cl bonds, rather than forming a disulfide
crosslink between TM3 and TM4. Such covalent attachment of a
single HgCl could interfere with the ability of butanol/isoflurane
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FIGURE 3 | Effect of crosslinking on alcohol responses in TM3-4
mutants. Tracings showing the effect of 22 mM butanol before and after
application of 10 µM HgCl2 on EC5−10 glycine-induced currents in individual
oocytes expressing wild-type (A) or A288C/Y410C (B) GlyRs. The upper bars
indicate butanol pre-application.
to bind or produce an effect at a TM domain cavity. It is unlikely
that formation of S-Hg-Cl bonds could explain the reduced
butanol/isoflurane effects because the effects were not altered
in the single mutants. Nevertheless, we measured butanol and
isoflurane modulation in the A288C/Y406C and A288C/I409C
mutants when HgCl2 was applied in the absence of glycine,
which likely prevents alcohol/anesthetic effects by preventing
crosslinking as reported previously (McCracken et al., 2010).
Potentiation of EC5−10 glycine responses by 22 mM butanol or
0.6 mM isoflurane was not altered in the A288C/Y406C mutant
under crosslinking conditions in the absence of glycine (data not
shown). HgCl2 (in the absence of glycine) also had no effect on
butanol or isoflurane modulation of the A288C/I409C mutant
(data not shown).
Crosslinking Using H2O2
The A288C/Y410C mutant showed evidence of crosslink
formation using either HgCl2 (S-Hg-S) or the oxidizing agent
H2O2 to induce disulfide bonds (S-S) (McCracken et al., 2010).
We tested the effectiveness of H2O2 in the I229C/A288C mutant
in order to verify crosslinking by an alternative method in
preparation for the proteomic experiments described below. We
observed evidence for crosslinking in the I229C/A288C mutant
after H2O2 similar to what we had previously observed using
HgCl2.We also tested the I229C/C290S and I229C/A288C/C290S
mutants to address the possibility that I229C in TM1 may
crosslink with the endogenous cysteine at position 290, instead
FIGURE 4 | Effect of crosslinking on anesthetic responses in TM3-4
mutants. Potentiation of EC5−10 glycine responses by 0.6 mM isoflurane
before and after HgCl2. (A) HgCl2 (10 µM) was applied to wild-type, double
(A288C/W407C, A288C/Y410C), and single mutants in the absence of glycine
(closed state). (B) HgCl2 (10 µM) was applied to wild-type, double
(A288C/Y406C, A288C/I409C), and single mutants in the presence of 100 mM
glycine (activated/desensitized state). Values represent mean ± SEM from 4 to
5 oocytes. Data from wild-type and A288C receptors were combined across
experiments and are represented in (A,B) and Figure 1B. Repeated measures
t-tests were used to detect differences between the pre-and post-HgCl2
conditions (*P < 0.05 compared to the pre-HgCl2 condition for each receptor).
of position A288C. In agreement with Lobo et al. (2008),
crosslinking was observed for the I229C/A288C double and
I229C/A288C/C290S triple mutants following application of
0.5% H2O2, based on the significantly decreased glycine-induced
current and subsequent reversal by disulfide bond reduction
using 10 mM DTT (Figure 5). However, no crosslinking was
observed for the wild-type, I229C single mutant, or I229C/C290S
double mutant (Figure 5). The I229C/A288C/C290S triple
mutant appears to form crosslinks in an almost identical manner
to that of I229C/A288C, suggesting that the endogenous cysteine
at position 290 is not responsible for the observed effects and that
crosslinking is likely occurring between I229 in TM1 and A288 in
TM3 of the adjacent subunit. Therefore, the I229C/A288C/C290S
mutant was not included in the remainder of the experiments,
and we focused on I229C/A288C as the representative TM1-3
mutant for further study.
Protein Identification
The presence of GlyR proteins expressed in oocytes injected
with wild-type or representative TM1-3 double mutant
(I229C/A288C) was verified by mass spectrometry under
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uncrosslinked and crosslinked conditions. Proteins were
resolved by 12% SDS-PAGE and 26 discrete specific bands
ranging from ∼30 to ∼140 kDa were visualized by Coomassie
staining, excised, digested with trypsin, and subjected to MALDI
ToF/ToF MS analysis (Table 1). Although the majority of the
proteins identified from the MS data originated from Xenopus
laevis, peptides matching GLRA1 sequence were detected in
16 bands by the MASCOT search engine (Table 2). Relative
protein C.I.% scores were slightly below the 90% confidence
interval (Supplementary Data); nevertheless, we considered
them as correct IDs considering the low amount of human
GLRA1 (compared to oocyte-derived proteins) and because
the presence of GLRA1 proteins in the preparation was
validated by immunoblotting. Among the proteins expressed
by oocytes injected with wild-type GlyRs, GLRA1 matching
peptides were only identified in the 50 kDa gel bands and not
in the ∼100 kDa bands, under uncrosslinked and crosslinked
conditions. In the case of double-mutants, GLRA1 peptides
were identified in bands of a broader molecular weight range;
however, protein C.I.% scores relative to the ∼100 kDa
bands were higher under crosslinking conditions. Further
inspection of the matching peptide sequences (Table 2) revealed
coverage for several GlyR subdomains, including the Cys-loop
region. Thus, MS analysis provided evidence for expression
of both monomeric and dimeric GlyR alpha 1 subunits
in oocytes.
Immunoblotting
To further investigate whether the proposed crosslinks are
formed between residues within the same subunit (intra-subunit)
or between subunits (inter-subunit), and whether these residues
are participating in alcohol sites of action within or between
GlyR subunits, we extracted proteins from oocytes injected with
wild-type, TM3-4 mutant (A288C/Y410C), or TM1-3 mutant
(I229C/A288C) GlyRs. We then used immunoblotting with a
GlyR alpha 1 antibody. When electrophoretically separated,
FIGURE 5 | Effect of crosslinking using H2O2 on maximal glycine
responses in TM1-3 mutants. The oxidizing agent, H2O2 (0.5%), was
applied in the presence of 100 mM glycine for 1 minute followed by a 15-min
washout. The response to glycine was measured and then the reducing agent
dithiothreitol (DTT, 10 mM) was applied for 3 min followed by a 15-min
washout. Values represent mean ± SEM from 3 to 6 oocytes (one-way ANOVA
with Tukey’s post-hoc test, *P < 0.05).
along with the proteins extracted fromwild-type injected oocytes,
expressed GlyRs were clearly detectable by immunoblotting as a
distinct ∼50–52 kDa band, as shown in Supplementary Figure
1. If crosslinking occurs between two adjacent subunits, an
increase in the presence of a GlyR-labeled ∼100 kDa band
(accompanied by a relative increase in the 100:50 kDa band
ratio) is expected under non-reducing conditions. Conversely,
no change would be expected in this ratio if crosslinking
occurs within a single subunit. Thus, the differences in the
100:50 kDa band ratios were quantified and compared between
uncrosslinked and crosslinked conditions for the representative
mutants andwild-type. The band ratio was significantly increased
in the I229C/A288C mutant after crosslinking (Supplementary
Figure 2 and Figure 6). However, in support of the hypothesis
that crosslinks to the TM4 subunit would be intra-subunit,
there were no differences in the 100:50 kDa band ratios
between the uncrosslinked or crosslinked conditions for the
TM3-4 mutant or wild-type (Supplementary Figure 3 and
Figure 6).
GlyR Homology Modeling
Our previous GlyR models were based on the prokaryotic
proton-gated GLIC structure (Bocquet et al., 2009). However, in
this study the homology model was based on the X-ray structure
of the eukaryotic ligand-gated GluCl (PDB ID 3RHW) (Hibbs
and Gouaux, 2011). Advantages of using GluCl as a template
include: the eukaryotic source, the high resolution of GluCl
structural data, and the greater sequence similarity between
FIGURE 6 | Semiquantitative analysis of dimeric/monomeric band
ratios resulting from uncrosslinked and crosslinked GlyRs. Crosslinking
was obtained by applying 0.5% H2O2 by bath perfusion. Equal amounts of
protein were extracted from oocytes, resolved by SDS-PAGE under
non-reducing conditions, and transferred to a membrane where a GlyR alpha
1 antibody was used. Immunoblot images were processed using ImageJ64
software, and GLRA1-labeled band intensity was obtained for 50 and 100 kDa
bands, which correspond to monomeric and dimeric GlyR subunits,
respectively. Band intensities are reported as direct ratios (100:50 kDa).
Immunoblot image analysis revealed a significant increase in the 100:50 kDa
band ratio for the I229/A288C (TM1-3) double mutant after crosslinking, but
not in the uncrosslinked mutant or in the corresponding wild-type samples.
Conversely, no differences in the 100:50 kDa band ratios were detected
between uncrosslinked (pre-H2O2) and crosslinked (post-H2O2) conditions for
the A288C/Y410C (TM3-4) double mutant or in the corresponding wild-type
samples. Statistically significant differences in band ratios between the
pre-H2O2 and post-H2O2 conditions were measured and reported as a ratio
(mean ± SEM; t-tests, *P < 0.05).
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TABLE 1 | GLRA1 protein identification by mass spectrometry.
# Sample type H2O2 Gel band MW (kDa) Peptide count GLRA1 matching peptides* Protein score Protein score C.I.%
1 WT No 115–120 –
2 100–105 –
3 100 –
4 50–55 3 dO, dCO, jO, mO 7 60
5 WT Yes 115–120 –
6 100–105 –
7 100 –
8 50–55 3 dO, jO, mO 7 59
9 DM No 130–140 –
10 115–120 3 g, hC, jO 7 59
11 100–105 3 g, hC, jO 7 59
12 100 –
13 50–55 4 f, hC, jO, mO 10 78
14 48–50 4 b, hC, jO, l 10 78
15 35 3 f, g, jO 7 60
16 30 4 c, g, hC, jO 9 76
17 DM Yes 130–140 –
18 115–120 3 e, g, hC 7 57
19 100–105 4 g, hC, jO, m 10 78
20 100 3 g, hC, jO 7 59
21 50–55 5 aO, f, hC, jO, mO 12 87
22 48–50 4 b, hC, jO, l 10 78
23 40 4 gC, hC, jO, k 9 77
24 35–37 –
25 30–32 5 c, g, hC, i, jO 12 89
26 28–30 5 c, g, hC, i, jO 13 89
For mass spectrometry experiments, proteins expressed in oocytes injected with wild-type (WT) or double mutant (DM), under uncrosslinked and crosslinked conditions, were resolved
by 12% SDS-PAGE and the resulting gels were subjected to Coomassie staining. Twenty-six discrete bands ranging from ∼30 to ∼140 kDa were excised, digested with trypsin, and
subjected to MALDI-ToF MS. GLRA1 theoretical molecular weight is 52,589.7 Daltons and the pI is 8.97. Apparent molecular weights of gel bands are indicated. GLRA1 was detected
in 16 bands, with several matching peptides. Protein score C.I.% indicates the confidence of the protein ID calculated from MS data. Note that the number of peptides sequenced does
not directly correlate to quantity of protein. *For information on matching peptide sequences, see Table 2.
the GlyR and GluCl compared to GLIC (McCracken et al.,
2010). Before using the structure for homology modeling, the
antibodies and ivermectin were removed. Unlike the questions
raised regarding the alignment (Ernst et al., 2005) of GlyR
with nAChR (PDB ID 2BG9) (Unwin, 2005), there were no
gaps in the alignment in the TM2-3 loop, and the similarity
of residues in TM4 was evident. The refined model was used
to suggest mutation of residues of interest to cysteine and
measure center-to-center distances between atoms to determine
potential sites for crosslinking. Distances between the C-alpha
atoms of cysteine substituted at A288 (TM3) and Y406, W407,
I409, and Y410 (TM4) within the same subunit were 14.7,
11.6, 15.3, and 14.6 Å, respectively (Figure 7A). In addition,
we used both the C-alpha and the S-S bond distances to show
the possible inter-subunit distances between the TM3 segment
of one subunit and the TM1 subunit of the adjacent subunit;
these inter-atomic distances were 10.3 and 7.8 Å, respectively
(Figure 7B).
DISCUSSION
Understanding high-resolution structures of alcohol/anesthetic
sensitive ion channels can facilitate the design and future
development of improved structure-based drugs (Harris et al.,
2008; Heusser et al., 2013; Gorini et al., 2014; Howard
et al., 2014). To this end, several studies have explored the
biochemical interactions of putative GlyR subunit residues that
may participate in alcohol/anesthetic sites of action. Residues
A288 in TM3 and Y406,W407, I409, and Y410 in TM4 are water-
accessible and may contribute to a hydrophilic, drug pocket
(Jenkins et al., 2001; Lobo et al., 2006, 2008; Harris et al., 2008).
The proximity of A288 in TM3 to these TM4 residues provided
evidence for crosslinking between TM3-4 (McCracken et al.,
2010). These studies indicated that TM3-4 regions participate
in an intra-subunit cavity. However, the homologous residue to
A288 in TM3 of the GABAAR is oriented toward the subunit
interface such that it is able to form crosslinks with TM1 residues
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TABLE 2 | GLRA1 matching peptide sequences identified by mass
spectrometry.
>sp|P23415|GLRA1_HUMAN
MYSFNTLRLY LWETIVFFSL AASKEAEAAR SAPKPMSPSD FLDKLMGRTS GYDARIRPNF 60
KGPPVNVSCN IFINSFGSIA ETTMDYRVNI FLRQQWNDPR LAYNEYPDDS LDLDPSMLDS 120
IWKPDLFFAN EKGAHFHEIT TDNKLLRISR NGNVLYSIRI TLTLACPMDL KNFPMDVQTC 180
IMQLESFGYT MNDLIFEWQE QGAVQVADGL TLPQFILKEE KDLRYCTKHY NTGKFTCIEA 240
RFHLERQMGY YLIQMYIPSL LIVILSWISF WINMDAAPAR VGLGITTVLT MTTQSSGSRA 300
SLPKVSYVKA IDIWMAVCLL FVFSALLEYA AVNFVSRQHK ELLRFRRKRR HHKSPMLNLF 360
QEDEAGEGRF NFSAYGMGPA CLQAKDGISV KGANNSNTTN PPPAPSKSPE EMRKLFIQRA 420
KKIDKISRIG FPMAFLIFNM FYWIIYKIVR REDVHNQ
# Start–End Domain Peptide Sequence and PTM
aO 31–44 Extracellular loop SAPKPMSPSDFLDK
b 94–100 Extracellular loop QQWNDPR
c 133–144 Extracellular loop GAHFHEITTDNK
dO 151–171 Extracellular loop NGNVLYSIRITLTLACPMDLK
dCO 151–171 Extracellular loop NGNVLYSIRITLTLACPMDLK
e 160–171 Extracellular loop ITLTLACPMDLK
f 225–234 Extracellular loop, Cys-Loop YCTKHYNTGK
fC 225–234 Extracellular loop, Cys-Loop YCTKHYNTGK
g 229–241 Extracellular loop HYNTGKFTCIEAR
gC 229–241 Extracellular loop HYNTGKFTCIEAR
hC 235–246 Extracellular loop, Cys-Loop FTCIEARFHLER
i 281–299 TM2 VGLGITTVLTMTTQSSGSR
jO 351–369 Cytoplasmic loop HHKSPMLNLFQEDEAGEGR
k 370–385 Cytoplasmic loop FNFSAYGMGPACLQAK
l 392–407 Cytoplasmic loop GANNSNTTNPPPAPSK
m 408–414 Cytoplasmic loop SPEEMRK
mO 408–414 Cytoplasmic loop SPEEMRK
Human GLRA1 protein sequence in FASTA format. Matching peptides identified by mass
spectrometry experiments are highlighted. Note that the numbering for all amino acid positions
cited in the text is relative to a shorter sequence lacking the first 28 amino acids, for consistency
with previous homology and modeling studies. Hence I229, S267, and A288 correspond to I257,
S295, and A316 in the FASTA sequence; Y410 corresponds to Y446. These four amino acids are
in bold text. In the columns, peptides matching GLRA1 sequence identified with the MASCOT
search engine following mass spectrometry. Sequences with amino acid residues, locations, and
post translational modifications (PTM) of peptides are indicated. Specific information on peptide
sequence matches for each gel band is included in Table 1. Superscripts O and C denote
Oxidation and Carbamidomethylation, respectively, in the highlighted amino acid.
of an adjacent subunit (Bali et al., 2009), and photoaffinity
labeling suggested that different classes of general anesthetics
may act at an inter-subunit site (Stewart et al., 2008; Zhong et al.,
2008; Li et al., 2010; Chiara et al., 2013). Crystallographic studies
using an ethanol-sensitized GLIC mutant co-crystallized with
ethanol, bromoethanol, and bromoform provided additional
support for an inter-subunit drug cavity (Sauguet et al., 2013).
These results differ, at least in part, from the recent x-ray structure
of desflurane bound at an intra-subunit cavity in the bacterial
homolog GLIC (Nury et al., 2010; Howard et al., 2011) and
suggest that alcohol and anesthetic interaction with GLIC may
involve more than a simple binding cavity operating between or
within subunits (Nury et al., 2010).
Based on the studies above, we aimed to determine whether
the critical residues are oriented to form a site of interaction
within the same subunit, between subunits, or both. We
mutated key residues with cysteines, which are able to form
disulfide bonds in the presence of crosslinking agents. Then we
FIGURE 7 | GLRA1 homology models based on GluCl showing TM3-4
intra-subunit and TM1-3 inter-subunit distances. (A) The enlarged boxed
area of a GLRA1 subunit shows distances between the C-alpha atoms of
cysteines substituted at A288 (TM3) and Y406, W407, I409, and Y410 (TM4)
within the same subunit were 14.7, 11.6, 15.3, and 14.6 Å, respectively. (B)
The enlarged boxed area of two GLRA1 subunits shows distances between
the C-alpha and S-S atoms of adjacent subunits (rendered as backbone
ribbons in red and purple) were 10.3 and 7.8 Å, respectively.
measured endogenous ligand-mediated current potentiation in
the presence of an agonist, assuming that when potentiation
occurs, the residue is accessible to the ligand. Conversely,
reduced or abolished potentiation after the application of a
crosslinking agent implies that the residue is not ligand accessible.
A reducing agent (DTT) would break crosslinks and reinstate
residue accessibility, as shown in our results. Collectively, our
electrophysiological experiments suggest that these residues
regulate accessibility to butanol/isoflurane sites of action.
We used mass spectrometry to verify the expression
and dimerization of double-mutant GlyR subunits and
immunoblotting to compare dimeric/monomeric band ratios
in uncrosslinked vs. crosslinked conditions. The reported
increase in the 100:50 kDa ratio observed after crosslinking in
I229C/288C, but absent in A288C/Y410C mutants or wild-type,
provides novel evidence for our model. Indeed, our current
work suggests that alcohol and anesthetic interactions with
the human GLRA1 subunit involve intra- and inter-subunit
sites, depending on the TM regions involved and the channel
activation conditions. Although we propose that crosslinking
most likely occludes butanol/isoflurane sites and prevent their
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effects, it is also plausible that drug interaction still occurs,
while crosslinking constrains either the side-chain or helix
rearrangements that are necessary for drug effects on channel
gating.
We initially used the crosslinking agent HgCl2, which reacts
with accessible cysteine pairs to form intermolecular S-Hg-
S dimers when the residues are in proximity to one another
and located on opposing faces of adjacent helices (Struthers
et al., 2000; Soskine et al., 2002), to provide insight into
the orientation and position of TM residues. An ideal C-
alpha distance in a disulfide bond is approximately 6 Å. The
use of HgCl2 to form an S-Hg-S bond extends that bond
distance to approximately 8 Å. GlyR homology modeling
using the GluCl template showed distances between the C-
alpha atoms of cysteine substituted at I229 (TM1), A288
(TM3), and Y406 (TM4) in two adjacent subunits ranged
from 7 to 12 Å (Figure 7). Inter-subunit crosslinks between
I229 in TM1 and A288 in TM3 would require a substantial
degree of flexibility in the upper portion of TM3 and about
a 100-degree rotation. This would permit A288 to crosslink
with I229 in TM1 across the subunit cleft, or alternatively
by rotating in the opposite direction, to crosslink with the
residues in TM4 (Y406, W407, I409, Y410) (Figure 7). This
seems plausible given that several of these mutants (I229 in
TM1 and Y406 and I409 in TM4) require co-application of
glycine with the crosslinking agent in order for crosslinking to
occur.
The position of A288C in our homology model and in
the recent cryo-electron microscopy and X-ray structures of
the GlyR (Du et al., 2015; Huang et al., 2015) is facing
more toward the inter-subunit space than toward the intra-
subunit cavity. However, the homology model shows that
the distances between A288C in TM3 of one subunit and
residues in TM4 of the adjacent subunit are so great, that
in either case, considerable distortion would be required for
crosslinking. A more likely possibility is that the crosslinking
to TM4 is intra-subunit and the two alpha helices at the
extracellular end of the TM domain are flexible. In fact, a
recent comparison of propofol binding in the TM domain of the
GABAAR in the open, closed, and desensitized states revealed
that most of the differences between these states occurred at the
extracellular end of TM2, the TM2-3 linker, and TM3 (Franks,
2015).
Previously, we considered the effect of a 100-degree rotation
of TM3 during the opening transition (McCracken et al., 2010).
There are now many reports demonstrating motion of TM3 or
global motion within subunits that changes the accessibility of
drugs to the intra-subunit cavity (Moraga-Cid et al., 2015). An
example of such motion was described in a molecular dynamics
simulation of the GluCl-ivermectin structure (Yoluk et al., 2013).
A more extreme example is a “spring model” used to explain the
effect of substitutions in TM3 of the nAChR (Otero-Cruz et al.,
2007). This model proposed extensive “fraying” and extension of
the alpha-helical structure at the extracellular end of TM3.
One uncertainty is the position and motion of TM4 in these
channels (Bertaccini et al., 2010). High-resolution structures of
GLIC, Erwinia chrysanthemi ligand-gated ion channel (ELIC),
and GluCl find TM4 to be tilted away from the other TM
regions (Bocquet et al., 2009; Hilf and Dutzler, 2009; Hibbs and
Gouaux, 2011) and the intra-subunit binding site for desflurane
in GLIC is formed primarily by TM1-3 (Nury et al., 2010).
It is possible that tilting of TM4 allows it to be partially or
completely surrounded by lipid (Baenziger and Corringer, 2011).
However, TM3 and TM4 were in sufficient proximity to allow
intra-subunit crosslinking using either HgCl2 or H2O2 in the
A288C/Y410C mutant (McCracken et al., 2010). Other work
indicates that W407C, I409C, Y410C, and K411C are accessible
to H2O2 and are likely exposed to water molecules, which is
consistent with this region of TM4 contributing to a water-
filled cavity (Lobo et al., 2006). It is likely that TM4 has
considerable flexibility and may approach the other TM regions,
perhaps during gating, which is supported by the observation
that crosslinking of A288C/Y406C and A288C/I409C are only
observed if the receptor is activated by glycine (McCracken et al.,
2010). We propose that alcohols and anesthetics help stabilize
the open state of GlyRs because this state facilitates a closer
orientation of TM4 to TM1-3, which allows stronger binding
to an intra-subunit site formed by all four TM segments (Yoluk
et al., 2015).
We note that speculations about “binding sites” or “sites of
interaction” are constrained by our studies and those of others
(Murail et al., 2011; Yoluk et al., 2015). These studies show that
the occupancy time of ligands is very transient (nanoseconds).
Thus small ligands, such as butanol and isoflurane, will not
reside in a single site during the course of an action potential
(microseconds to milliseconds). As a result, we are likely viewing
an ensemble average of the interactions of these ligands with
GLRA1. Studies of the GABAAR showed that under conditions
where anesthetics occlude initial rates of substituted cysteine
modification, the rate of inhibition (as a measure of anesthetic
site occupancy) indicates that a high degree of time-averaged site
occupancy can be achieved when receptors are in a high-affinity
state or drug concentrations are very high (Stewart et al., 2013).
Our work shows that crosslinking between A288 in TM3
and I229 in TM1 or between A288 and Y406, W407, I409,
or Y410 in TM4 strongly reduces the ability of butanol and
isoflurane to potentiate glycine-induced currents and supports
participation of these residues in alcohol/anesthetic sites of
action. The application of different proteomic methodologies
provides additional support, suggesting that the TM1 and 3
segments likely participate in an inter-subunit site (between
adjacent GlyR alpha 1 subunits), while TM3-4 participate in an
intra-subunit site (within the same alpha 1 subunit). The recent
publication of a high-resolution structure of a chimera between
the TMdomain of the GlyR and the extracellular domain of GLIC
reveals many details of the interacting domains (Moraga-Cid
et al., 2015). Moreover, new electron cryo-microscopy structures
of zebrafish GlyRs at intermediate resolutions (Du et al., 2015)
provide strong support for our use of the GluCl structure as
a template for homology modeling. These new GlyR structures
are at an estimated resolution of only 3.8–3.9 Å, and have
some missing side chains. In addition, a three-residue loop
is substituted for the intracellular TM3-4 loop. Nevertheless,
the set of three self-consistent structures in the resting, open,
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and desensitized states offers many opportunities for their use
in directed molecular dynamics simulations of the transitions
between these states. Overall, the considerations above support
our choice of GluCl as a good template for the present
studies.
It is interesting to consider that the protein segments studied
here may be part of the dark “proteome” as defined by
Perdigão et al. (2015), even though these regions were not
considered “dark” under the strict criteria used by Perdigao
and coworkers because their structures have been identified
in the Protein Data Bank (PDB; Berman et al., 2000).
However, inspection of the GlyR in the resting, open, and
desensitized states (Du et al., 2015), reveals that these segments
spend much of their time undergoing transitions between
the three states along unknown pathways. These transition
pathways, which include twisting, blooming, and exchange of
electrostatic bonds, are supported by our data, which can
only be explained by large excursions from the known PDB
structures.
Our results are consistent with the x-ray structure of
desflurane bound at an intra-subunit cavity in the homolog
GLIC (Nury et al., 2010). The high-resolution structure of GLIC
with desflurane shows a “linking tunnel” which connects the
inter- and intra-subunit cavities (Nury et al., 2010), and alcohol
action on mutant GLIC channels suggests that the tunnel may
also be important for enhancement of function by short chain
alcohols (Howard et al., 2011). This tunnel that links intracellular
sites with sites at the domain interface is very similar to a
tunnel revealed by previous homology modeling of the GlyR
(Crawford et al., 2007). Insights from these structures and
our current model using GluCl, combined with our functional
evidence in oocytes, point to an interaction of isoflurane and
butanol with alpha 1 subunits that is more complex than
a single site surrounded by four TM helices. Our results
suggest a multi-site model for alcohol/anesthetic interaction
within human GLRA1 subunits. In this model, crosslinking may
prevent access to sites of drug action or produce conformational
changes that interfere with alcohol/anesthetic-induced channel
gating.
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